Business
A New Theranostics Center of Excellence in Europe: GE HealthCare and University Medicine Essen Collaborate to Advance Theranostics and Personalized Medicine
Bringing together leading global healthcare innovator and European healthcare institutions, this relationship aims to advance Theranostics in clinical
About this update from Ge Healthcare Technologies Inc.
[{"type":"text","content":"\n\nBringing together leading global healthcare innovator and European healthcare institutions, this relationship aims to advance Theranostics in clinical practice and the development of new tracers and technologies for more personalized medicine\n\n\nTheranostics is a transformative approach to cancer treatment, giving hope to patients and their loved ones and the potential for an improved quality of life\n\n\nThe practice of Theranostics is supported by advanced imaging devices as well as digital and artificial intelligence (AI) solutions\n\n\n CHICAGO--(BUSINESS WIRE)--\nWith the aim of increasing access to precision care, GE HealthCare is proud to collaborate with University Medicine Essen (UME) in the establishment of a new Theranostics Center of Excellence. The Center will be outfitted with the latest technologies and solutions to support the clinical practice and advanced research of more personalized approaches to cancer care in Germany and around the world.\n\nCancerous diseases continue to threaten the lives of patients, with over 10 million new cancer cases diagnosed annually.i Fortunately, the advancement of precision diagnostics solutions and regulatory approval of new treatment options enables the growing practice of precision care – namely Theranostics – giving hope to patients and their loved ones and the potential for an improved quality of life.\n\n\"Theranostics has revolutionized the way we approach patient care by combining targeted therapy with precise diagnostic tools, offering a personalized treatment strategy,” shares Ken Herrmann, MD, director and chair, scientific advisory board at the Clinic for Nuclear Medicine, University Medicine Essen. “This growing practice allows us to deliver treatments that are tailored to each patient's specific condition. However, the true potential of Theranostics can only be fully realized with continuous research and development. As we advance precision medicine, it is crucial that we collaborate with industry leaders – like GE HealthCare – and invest in innovation to refine and expand personalized medicine, helping ensure even better outcomes for patients in the future.\"\n\nTheranostics represents a growing medical practice, leveraging diagnostic tools to precisely diagnose and monitor disease for the targeted delivery of therapy to patients. These therapeutic and diagn...